Enochian Biosciences Inc. (ENOB)
NASDAQ: ENOB
· Real-Time Price · USD
0.71
0.01 (1.43%)
At close: Aug 04, 2023, 7:58 PM
1.43% (1D)
| Bid | n/a |
| Market Cap | 45.38M |
| Revenue (ttm) | 181.45K |
| Net Income (ttm) | -84.22M |
| EPS (ttm) | -2.07 |
| PE Ratio (ttm) | -0.3442028985507246 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 87,289 |
| Avg. Volume (20D) | 254,603 |
| Open | 0.73 |
| Previous Close | 0.70 |
| Day's Range | 0.70 - 0.74 |
| 52-Week Range | 0.39 - 2.99 |
| Beta | 0.94 |
About ENOB
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-11, a preventative HIV vaccine; ENOB-HV-12, a therapeutic HIV ...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 7, 2018
Employees 22
Stock Exchange NASDAQ
Ticker Symbol ENOB
Website https://www.enochianbio.com